FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2131899080> ?p ?o ?g. }

• W2131899080 endingPage "2178" @default.
• W2131899080 startingPage "2173" @default.
• W2131899080 abstract "BackgroundWe aimed to analyze prognostic factors for relapse in stage I seminoma managed by either active surveillance or adjuvant chemotherapy, and to describe the long-term patterns of recurrence in both groups.Patients and methodsFrom 1994 to 2008, 744 patients were included in three consecutive, prospective risk-adapted studies by the Spanish Germ Cell Cancer Group. Low-risk patients were managed by surveillance and high-risk patients were given two courses of adjuvant carboplatin. Relapses were treated mainly with chemotherapy. Patient age, tumor size, histological variant, pT staging, rete testis invasion, and preoperative serum BHCG levels were assessed for prediction of disease-free survival (DFS).ResultsAfter a median follow-up of 80 months, 63 patients (11.1%) have relapsed: 51/396 (14.8%) on surveillance and 12/348 (3.2%) following adjuvant carboplatin. Actuarial overall 5-year DFS was 92.3% (88.3% for surveillance versus 96.8% for chemotherapy, P = 0.0001). Median time to relapse was 14 months. Most recurrences were located at retroperitoneum (86%), with a median tumor size of 26 mm. All patients were rendered disease-free with chemotherapy (92%), radiotherapy (5%), or surgery followed by chemotherapy (3%). A nomogram was developed from surveillance patients that includes two independent, predictive factors for relapse: rete testis invasion and tumor size (as a continuous variable).ConclusionLong-term follow-up confirms the risk-adapted approach as an effective option for patients with stage I seminoma. The pattern of relapses after adjuvant chemotherapy is similar to that observed following surveillance. A new nomogram for prediction of DFS among patients on surveillance is proposed. Rete testis invasion and tumor size should be taken into account when considering the administration of adjuvant carboplatin. Prospective validation is warranted." @default.
• W2131899080 created "2016-06-24" @default.
• W2131899080 creator A5005072118 @default.
• W2131899080 creator A5005116367 @default.
• W2131899080 creator A5006532865 @default.
• W2131899080 creator A5019966752 @default.
• W2131899080 creator A5020462811 @default.
• W2131899080 creator A5023753029 @default.
• W2131899080 creator A5024147987 @default.
• W2131899080 creator A5027128322 @default.
• W2131899080 creator A5031374790 @default.
• W2131899080 creator A5038937574 @default.
• W2131899080 creator A5046235052 @default.
• W2131899080 creator A5053021947 @default.
• W2131899080 creator A5055824195 @default.
• W2131899080 creator A5059227006 @default.
• W2131899080 creator A5059942977 @default.
• W2131899080 creator A5060170484 @default.
• W2131899080 creator A5072507663 @default.
• W2131899080 creator A5073742272 @default.
• W2131899080 creator A5079225557 @default.
• W2131899080 creator A5087329014 @default.
• W2131899080 creator A5089909302 @default.
• W2131899080 date "2014-11-01" @default.
• W2131899080 modified "2023-10-18" @default.
• W2131899080 title "Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG)" @default.
• W2131899080 cites W1525322843 @default.
• W2131899080 cites W1540798462 @default.
• W2131899080 cites W1566820657 @default.
• W2131899080 cites W1965955251 @default.
• W2131899080 cites W1975032910 @default.
• W2131899080 cites W1978174896 @default.
• W2131899080 cites W2032957430 @default.
• W2131899080 cites W2065845140 @default.
• W2131899080 cites W2105475112 @default.
• W2131899080 cites W2113967524 @default.
• W2131899080 cites W2120873957 @default.
• W2131899080 cites W2122178864 @default.
• W2131899080 cites W2133050123 @default.
• W2131899080 cites W2136265852 @default.
• W2131899080 cites W2146770164 @default.
• W2131899080 cites W2158551593 @default.
• W2131899080 cites W2163911083 @default.
• W2131899080 cites W2170763390 @default.
• W2131899080 cites W4240792549 @default.
• W2131899080 doi "https://doi.org/10.1093/annonc/mdu437" @default.
• W2131899080 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25210015" @default.
• W2131899080 hasPublicationYear "2014" @default.
• W2131899080 type Work @default.
• W2131899080 sameAs 2131899080 @default.
• W2131899080 citedByCount "97" @default.
• W2131899080 countsByYear W21318990802015 @default.
• W2131899080 countsByYear W21318990802016 @default.
• W2131899080 countsByYear W21318990802017 @default.
• W2131899080 countsByYear W21318990802018 @default.
• W2131899080 countsByYear W21318990802019 @default.
• W2131899080 countsByYear W21318990802020 @default.
• W2131899080 countsByYear W21318990802021 @default.
• W2131899080 countsByYear W21318990802022 @default.
• W2131899080 countsByYear W21318990802023 @default.
• W2131899080 crossrefType "journal-article" @default.
• W2131899080 hasAuthorship W2131899080A5005072118 @default.
• W2131899080 hasAuthorship W2131899080A5005116367 @default.
• W2131899080 hasAuthorship W2131899080A5006532865 @default.
• W2131899080 hasAuthorship W2131899080A5019966752 @default.
• W2131899080 hasAuthorship W2131899080A5020462811 @default.
• W2131899080 hasAuthorship W2131899080A5023753029 @default.
• W2131899080 hasAuthorship W2131899080A5024147987 @default.
• W2131899080 hasAuthorship W2131899080A5027128322 @default.
• W2131899080 hasAuthorship W2131899080A5031374790 @default.
• W2131899080 hasAuthorship W2131899080A5038937574 @default.
• W2131899080 hasAuthorship W2131899080A5046235052 @default.
• W2131899080 hasAuthorship W2131899080A5053021947 @default.
• W2131899080 hasAuthorship W2131899080A5055824195 @default.
• W2131899080 hasAuthorship W2131899080A5059227006 @default.
• W2131899080 hasAuthorship W2131899080A5059942977 @default.
• W2131899080 hasAuthorship W2131899080A5060170484 @default.
• W2131899080 hasAuthorship W2131899080A5072507663 @default.
• W2131899080 hasAuthorship W2131899080A5073742272 @default.
• W2131899080 hasAuthorship W2131899080A5079225557 @default.
• W2131899080 hasAuthorship W2131899080A5087329014 @default.
• W2131899080 hasAuthorship W2131899080A5089909302 @default.
• W2131899080 hasBestOaLocation W21318990801 @default.
• W2131899080 hasConcept C126322002 @default.
• W2131899080 hasConcept C141071460 @default.
• W2131899080 hasConcept C143998085 @default.
• W2131899080 hasConcept C146357865 @default.
• W2131899080 hasConcept C151730666 @default.
• W2131899080 hasConcept C2776694085 @default.
• W2131899080 hasConcept C2778074268 @default.
• W2131899080 hasConcept C2778239845 @default.
• W2131899080 hasConcept C2781451048 @default.
• W2131899080 hasConcept C34626388 @default.
• W2131899080 hasConcept C509974204 @default.
• W2131899080 hasConcept C71924100 @default.
• W2131899080 hasConcept C86803240 @default.
• W2131899080 hasConceptScore W2131899080C126322002 @default.
• W2131899080 hasConceptScore W2131899080C141071460 @default.

• next